• Users Online: 514
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2022  |  Volume : 19  |  Issue : 4  |  Page : 589-594

Incidence of acute kidney injury in hospitalized COVID-19 patients


1 Department of Family and Community Medicine, College of Medicine, University of Babylon, Hilla, Babil, Iraq
2 Department of Medicine, College of Medicine, University of Babylon, Hilla, Babil, Iraq

Correspondence Address:
Yasamine Abdul Hussein Abdul Waheed
Department of Family and Community Medicine, College of Medicine, University of Babylon, Hilla, Babil
Iraq
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/MJBL.MJBL_143_22

Rights and Permissions

Background: Acute kidney injury (AKI) is common among patients hospitalized with COVID-19 and associated with worse prognosis. Objective: We aim to assess the incidence of AKI in hospitalized COVID-19 patients. Materials and Methods: This is a retrospective cross-sectional study conducted at Merjan Teaching Hospital from May 1 to October 1, 2021. It involved a review of data of 174 hospitalized polymerase chain reaction–confirmed COVID-19 patients from hospital health records. Results: In our hospitalized COVID-19 patients, AKI was found in 14 patients forming 8.05% of the total hospitalized patients. The age of participants with AKI was 62.64 ± 19.08 years; male patients formed the larger proportion (53.45%). More than one-third of the patients (36.21%) had a history of hypertension, and more than one-fifth of the patients had a history of diabetes mellitus (22.99%). History of ischemic heart disease was present in 4.60%, heart failure in 0.57%, asthma in 3.45%, chronic obstructive pulmonary disease in 1.15%, cerebrovascular accidents in 1.75%, and lung fibrosis in 1.15%. Patients with AKI had a significantly higher level of blood urea (22.44 ± 11.74); the level of serum creatinine was also significantly higher among patients with AKI (267.57 ± 87.27); significant relationship was observed between the outcome of the patient and the incidence of AKI. Conclusions: The current study showed a higher risk of mortality and morbidity in COVID-19 patients with AKI. Identifying high-risk groups and earlier diagnosis of AKI in COVID-19 patients can improve results in patients and decrease mortality.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed100    
    Printed8    
    Emailed0    
    PDF Downloaded17    
    Comments [Add]    

Recommend this journal